Amitriptyline in the treatment of primary headaches

References

• Rasmussen BK, Jensen R, Schroll M, Olesen J. Epidemiology of headache in a general population, a prevalence study. J. Clin. Epidemial 44,1147–1157 (1991).
   PubMed Web of Science ®Google Scholar
• Pryse-Phillips W, Findlay H, Tugwell P, Edmeads J, Murray TJ, Nelson RE A Canadian population a survey on the clinical, epidemiologic and societal impact of migraine and tension-type headache. Can. J. Neural Sc]. 19,333–339 (1992).
   PubMed Web of Science ®Google Scholar
• Lipton RB, Scher AT, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: epidemiology and patterns of healthcare use. Neurology58, 885–894 (2002).
   PubMed Web of Science ®Google Scholar
• Headache Classification Committee of the International Headache Society. Classification and Diagnostic Criteria for Headache Disorders, Cranial Neuralgias and Facial Pain. Cephalalgia 8\(Suppl. 7), 1–96 (1988).
   Google Scholar
• Rasmussen BK, Jensen R, Olesen J. Impact of headache on sickness absence and utilisation of medical services: a Danish population study. J. Epidemial Community Health 46,443–446 (1992).
   Google Scholar
• Schwartz BS, Stewart WF, Lipton RB. Lost workdays and decreased work effectiveness associated with headache in the workplace. Occup. Environ. Med. 39,320–327 (1997).
   Google Scholar
• Hu XH, Markson LE, Lipton RB, Stewart WE Berger ML. Burden of migraine in the United States: disability and economic costs. Arch. Intern Med. 159,813-818 (1999).
   Google Scholar
• Goadsby PJ, Lipton RB, Ferrari MD. Migraine: current understanding and treatment. N Engl. J. Med. 346,257-270 (2002).
   Google Scholar
• ••Excellent review of migrainepathophysiology and treatment.
   Google Scholar
• Moskowitz MA, Henrikson BM, Markowitz S, Saito K. Intra and extracraniovascular nociceptive mechanisms and the pathogenesis of head pain. In: Basic Mechanisms of Headache. Olesen J, Edvinsson L (Eds). Elsevier Science Publishers B.V., Amsterdam, The Netherlands 429–437 (1988).
   Google Scholar
• Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann. Neural 33,48–56 (1993).
   PubMed Web of Science ®Google Scholar
• Jensen R. Pathophysiological mechanisms of tension-type headache: a review of epidemiological and experimental studies. Cephalalgia 19,602–621 (1999).
   PubMed Web of Science ®Google Scholar
• Bendtsen L. Central sensitization in tension-type headache: possible pathophysiological mechanisms. Cephalalgia 20,486–508 (2000).
   PubMed Web of Science ®Google Scholar
• Ashina M, Stallknecht B, Bendtsen L eta]. Tender points are not sites of ongoing inflammation, in vivo evidence in patients with chronic tension-type headache. Cephalalgia (In press) (2003).
   Google Scholar
• Goadsby PJ, Boes C. Chronic daily headache. J. Neural Neumsurg. fiychiatry 72\(Suppl. 2), ii2—ii5 (2002).
   Google Scholar
• Katsarava Z, Fritsche G, Muessig M, Diener HC, Limmroth V Clinical features of withdrawal headache following overuse of triptans and other headache drugs. Neurology57, 1694–1698 (2001).
   PubMed Web of Science ®Google Scholar
• Leston JA. Migraine and tension-type headaches are not separate disorders. Cephalalgia 16,220–222 (1996).
   Google Scholar
• Olesen J. Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs. Pain 46,125–132 (1991).
   PubMed Web of Science ®Google Scholar
• Rasmussen BK. Migraine and tension-type headache are separate disorders. Cephalalgia 16,217–220 (1996).
   PubMedGoogle Scholar
• Silberstein S, Goadsby PJ. Migraine: preventive treatment. Cephalalgia 22,491–512 (2002).
   PubMed Web of Science ®Google Scholar
• •Recent overview of prophylactic migraine treatment.
   Google Scholar
• Tfelt-Hansen P, De Vries P, Saxena PR. Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy. Drugs 60,1259–1287 (2000).
   PubMed Web of Science ®Google Scholar
• Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (serotonin 5-HT(1B/ID) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 358, 1668–1675 (2001).
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P, Mulder LJ, Scheldewaert RG, Schoenen J, Chazot G. The effectiveness of combined oral lysine acetylsalicylate and metoclopramide compared with oral sumatriptan for migraine. Lancet 346,923–926 (1995).
   Google Scholar
• Silberstein SD. Preventive treatment of migraine: an overview. Cephalalgia 17,67–72 (1997).
   PubMed Web of Science ®Google Scholar
• Becker WJ. Evidence based migraine prophylactic drug therapy. Can. J. Neural Li. 26\(Suppl. 3), S27—S32 (1999).
   Google Scholar
• Ramadan NM, Schultz LL, Gilkey SJ. Migraine prophylactic drugs: proof of efficacy, utilization and cost. Cephalalgia 17,73–80 (1997).
   PubMed Web of Science ®Google Scholar
• •Comprehensive overview of prophylactic migraine treatment.
   Google Scholar
• Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology55, 754–762 (2000).
   PubMed Web of Science ®Google Scholar
• Silberstein SD, Goadsby PJ, Lipton RB. Management of migraine: an algorithmic approach. Neurology55, S46—S52 (2000).
   Google Scholar
• Mylecharane EJ, Tfelt-Hansen Nonsteroidal antiinflammatory and miscellaneous drugs in migraine prophylaxis. In: The Headaches. 2nd ed. Olesen J, Tfelt-Hansen P, Welch KM (Eds). Lippincott, Williams and Wilkins, MD, USA 489–498 (2000).
   Google Scholar
• Diener HC, Limmroth V. Advances in pharmacological treatment of migraine. Expert. Opin. Investig. Drugs 10, 1831–1845 (2001).
   PubMed Web of Science ®Google Scholar
• Mathew NT, Schoenen J. Acute pharmacotherapy of tension-type headache. In: The Headaches. 2nd ed. Olesen J, Tfelt-Hansen P, Welch KM (Eds). Lippincott Williams and Wilkins, 661–666 (2000).
   Google Scholar
• Mathew NT, Bendtsen L. Prophylactic pharmacotherapy of tension-type headache. In: The Headaches. 2 ed Olesen J, Tfelt-Hansen P, Welch KM (Eds). Lippincott, Williams and Wilkins, MD, USA, 667–673 (2000).
   Google Scholar
• ••Comprehensive overview of theprophylactic management of chronic tension-type headache.
   Google Scholar
• Lance JW, Curran DA. Treatment of chronic tension headache. Lancet1,1236–1239 (1964).
   PubMed Web of Science ®Google Scholar
• Gomersall JD, Stuart A. Amitriptyline in migraine prophylaxis. Changes in pattern of attacks during a controlled clinical trial. J. Neural Neurosurg. Ptychiatry36,684–690 (1973).
   PubMed Web of Science ®Google Scholar
• Frazer A. Pharmacology of antidepressants. Clin. Psychophatmacal 17, 2S-18S (1997).
   Google Scholar
• Westenberg HG. Pharmacology of antidepressants: selectivity or multiplicity?' Clin. Psychiatry60\(Suppl. 17), 4–8 (1999).
   Google Scholar
• Botney M, Fields HL. Amitriptyline potentiates morphine analgesia by a direct action on the central nervous system. Ann. Neural. 13, 160–164 (1983).
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Saito H, Abe K Tricyclic antidepressants block NMDA receptor-mediated synaptic responses and induction of long-term potentiation in rat hippocampal slices. NelffOphatmacology32, 479–486 (1993).
   PubMed Web of Science ®Google Scholar
• Couch JR, Hassanein RS. Amitriptyline in migraine prophylaxis. Arch. Neural. 36, 695–699 (1979).
   PubMed Web of Science ®Google Scholar
• Ziegler DK, Hurwitz A, Hassanein RS, Kodanaz HA, Preskom SH, Mason J. Migraine prophylaxis. A comparison of propranolol and amitriptyline. Arch. Neural. 44, 486–489 (1987).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R, Olesen J. A nonselective (amitriptyline) but not a selective (citalopram), serotonin re-uptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. j Neural. Neurosurg. Psychiatry 61, 285–290 (1996).
   Google Scholar
• •Well-conducted trial demonstrating the efficacy of a tricyclic antidepressant in chronic tension-type headache, while a selective serotonin re-uptake inhibitor had no effect.
   Google Scholar
• Goadsby PJ. How do the currently used prophylactic agents work in migraine? Cephalalgia 17, 85–92 (1997).
   PubMed Web of Science ®Google Scholar
• Terron JA. Is the 5-HT(7) receptor involved in the pathogenesis and prophylactic treatment of migraine? Eur j Pharmacol 439, 1–11 (2002).
   PubMed Web of Science ®Google Scholar
• Bryson HM, Wilde MI. Amitriptyline. A review of its pharmacological properties and therapeutic use in chronic pain states. Drugs Aging8, 459–476 (1996).
   Google Scholar
• Bendtsen L. Sensitization: its role in primary headache. Cum Opin. Investig. Drugs 3, 449–453 (2002).
   Google Scholar
• Cerbo R, Barbanti P, Fabbrini G, Pascali MP, Catarci T Amitriptyline is effective in chronic but not in episodic tension-type headache: pathogenetic implications. Headache 38, 453–457 (1998).
   PubMedGoogle Scholar
• Sawynok J, Reid AR, Esser MJ. Peripheral antinociceptive action of amitriptyline in the rat formalin test: involvement of adenosine. Pain 80, 45–55 (1999).
   PubMed Web of Science ®Google Scholar
• Bendtsen L, Jensen R. Amitriptyline reduces myofascial tenderness in patients with chronic tension-type headache. Cephalalgia 20, 603–610 (2000).
   PubMed Web of Science ®Google Scholar
• Weber S. Drug interactions with antidepressants. CNS Special Edition 1,47–55 (1999).
   Google Scholar
• Tfelt-Hansen P, Block G, Dahlof C et al Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia 20, 765–786 (2000).
   PubMed Web of Science ®Google Scholar
• Schoenen J. Guidelines for trials of drug treatments in tension-type headache. First edition: International Headache Society Committee on Clinical Trials. Cephalalgia 15, 165–179 (1995).
   PubMed Web of Science ®Google Scholar
• Mathew NT Prophylaxis of migraine and mixed headache. A randomized controlled study. Headache 21, 105–109 (1981).
   Google Scholar
• Bank J. A comparative study of amitriptyline and fluvoxamine in migraine prophylaxis. Headache 34, 476–478 (1994).
   Google Scholar
• Bonuso S, Di Stasio E, Barone P, Steardo L. Timed release dihydroergotamine in the prophylaxis of mixed headache. A study versus amitriptyline. Cephalalgia 3 (Suppl. 1), 175–178 (1983).
   Google Scholar
• Diamond S, Baltes BJ. Chronic tension headache treated with amitriptyline, a double-blind study. Headache 11, 110–116 (1971).
   PubMed Web of Science ®Google Scholar
• Göbel H, Hamouz V, Hansen C et al Chronic tension-type headache: amitriptyline reduces clinical headache duration and experimental pain sensitivity but does not alter pericranial muscle activity readings. Pain 59, 241–249 (1994).
   PubMed Web of Science ®Google Scholar
• Pfaffenrath V, Diener HC, Isler H etal Efficacy and tolerability of amitriptylinoxide in the treatment of chronic tension-type headache: a multi centre controlled study. Cephalalgia 14, 149–155 (1994).
   PubMed Web of Science ®Google Scholar
• Holroyd kA, O'Donnell FJ, Stensland M, Lipchik GL, Cordingley GE, Carlson BW. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy and their combination: a randomized controlled trial. JA/V/A 285, 2208–2215 (2001).
   Google Scholar
• •Well-conducted, 6-month trial of amitriptyline and stress management therapy in chronic tension-type headache.
   Google Scholar
• Holroyd kA, Nash JM, Pingel JD, Cordingley GE, Jerome A. A comparison of pharmacological (amitriptyline HCL) and nonpharmacological (cognitive—behavioral) therapies for chronic tension headaches. Consult. Clin. PTchol. 59, 387–393 (1991).
   Google Scholar
• Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 40, 539–549 (2000).
   PubMed Web of Science ®Google Scholar
• Krymchantowski AV, Bigal ME, Moreira PE New and emerging prophylactic agents for migraine. CNS Drugs 16, 611–634 (2002).
   PubMed Web of Science ®Google Scholar
• ••Comprehensive review on new andemerging drugs for prophylactic treatment of migraine.
   Google Scholar
• Ashina M, Lassen LH, Bendtsen L, Jensen R, Olesen J. Effect of inhibition of nitric oxide synthase on chronic tension-type headache: a randomised crossover trial. Lancet353, 287–289 (1999).
   PubMed Web of Science ®Google Scholar
• Kranzler JD, Gendreau JF, Rao SG. The psychopharmacology of fibromyalgia: a drug development perspective. PTchophatmacol Bull 36, 165–213 (2002).
   PubMedGoogle Scholar